Hourly Oral Misoprostol Administration for Terminating Midtrimester Pregnancies: A Pilot Study

Taiwanese Journal of Obstetrics and Gynecology

Volumn 49, Issue 4, 2010, Pages 438-441

  Cheng, Shi Yann ^a   Hsue, Chao Song ^a   Hwang, Geen Hour ^a   Tsai, Li Chuan ^a   Pei, Shu Chen ^a  

^a CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

Author keywords

Medical induction; Midtrimester pregnancy; Misoprostol

Indexed keywords

MISOPROSTOL;

ADULT; ARTICLE; BODY HEIGHT; CONTROLLED STUDY; CURETTAGE; DIARRHEA; FEMALE; FETUS WEIGHT; FEVER; GESTATION PERIOD; GESTATIONAL AGE; HUMAN; LABOR INDUCTION; NAUSEA; NORMAL HUMAN; PILOT STUDY; PREGNANCY OUTCOME; PREGNANCY TERMINATION; RETAINED PLACENTA; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; SHIVERING; VAGINAL DELIVERY; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADOLESCENT; ADULT; FEMALE; GESTATIONAL AGE; HUMANS; MISOPROSTOL; PILOT PROJECTS; PREGNANCY; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 78650726448     PISSN: 10284559     EISSN: 10284559     Source Type: Journal    
DOI: 10.1016/S1028-4559(10)60095-2     Document Type: Article

References (20)

1. Yapar EG, Senoz S, Urkutur M, Batioglu S, Gokmen O Second trimester pregnancy termination including fetal death: comparison of five different methods. Eur J Obstet Gynecol Reprod Biol 1996, 69:97-102.
2. Ramsey PS, Owen J Midtrimester cervical ripening and labor induction. Clin Obstet Gynecol 2000, 43:495-512.
3. Owen J, Hauth JC, Winkler CL, Gray SE Midtrimester pregnancy termination: a randomized trial of prostaglandin E2 versus concentrated oxytocin. Am J Obstet Gynecol 1992, 167:1112-1116.
4. Owen J, Hauth JC Concentrated oxytocin plus low-dose prostaglandin E2 compared with prostaglandin E2 vaginal suppositories for second-trimester pregnancy termination. Obstet Gynecol 1996, 88:110-113.
5. de Boer MA, van Gemund N, Scherjon SA, Kanhai HH Low dose sulprostone for termination of second and third trimester pregnancies. Eur J Obstet Gynecol Reprod Biol 2001, 99:244-248.
6. Bebbington MW, Kent N, Lim K, et al. A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination. Am J Obstet Gynecol 2002, 187:853-857.
7. Herabutya Y, O-Prasertsawat P Second trimester abortion using intravaginal misoprostol. Int J Gynaecol Obstet 1998, 60:161-165.
8. Dickinson JE, Evans SF The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination. Am J Obstet Gynecol 2002, 186:470-474.
9. Ramin KD, Ogburn PL, Danilenko DR, Ramsey PS High-dose oral misoprostol for mid-trimester pregnancy interruption. Gynecol Obstet Invest 2002, 54:176-179.
10. Ramsey PS, Savage K, Lincoln T, Owen J Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction. Obstet Gynecol 2004, 104:138-145.
11. Nuthalapaty FS, Ramsey PS, Biggio JR, Owen J High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial. Am J Obstet Gynecol 2005, 193:1065-1070.
12. Tang OS, Schweer H, Seyberth HW, Lee SW, Ho PC Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002, 17:332-336.
13. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997, 90:88-92.
14. Cheng SY, Ming H, Lee JC Titrated oral compared with vaginal misoprostol for labor induction: a randomized controlled trial. Obstet Gynecol 2008, 111:119-125.
15. Collins PW Misoprostol: Discovery, development and clinical applications. Med Res Rev 1990, 10:149-172.
16. Bond GR, Van Zee A Overdosage of misoprostol in pregnancy. Am J Obstet Gynecol 1994, 171:561-562.
17. Graber DJ, Meier KH Acute misoprostol toxicity. Ann Emerg Med 1991, 20:549-551.
18. Austin J, Ford MD, Rouse A, Hanna E Acute intravaginal misoprostol toxicity with fetal demise. J Emerg Med 1997, 15:61-64.
19. Phillips K, Berry C, Mathers AM Uterine rupture during second trimester termination of pregnancy using mifepristone and a prostaglandin. Eur J Obstet Gynecol Reprod Biol 1996, 65:175-176.
20. Weeks AD The retained placenta. Best Pract Res Clin Obstet Gynaecol 2008, 22:1103-1117.